Literature DB >> 12423377

Voltage-gated sodium channels in epilepsy.

Rüdiger Köhling1.   

Abstract

Animal experiments, and particularly functional investigations on human chronically epileptic tissue as well as genetic studies in epilepsy patients and their families strongly suggest that some forms of epilepsy may share a pathogenetic mechanism: an alteration of voltage-gated sodium channels. This review summarizes recent data on changes of sodium channel expression, molecular structure and function associated with epilepsy, as well as on the interaction of new and established antiepileptic drugs with sodium currents. Although it remains to be determined precisely how and to what extent altered sodium-channel functions play a role in different epilepsy syndromes, future promising therapy approaches may include drugs modulating sodium currents, and particularly substances changing their inactivation characteristics.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12423377     DOI: 10.1046/j.1528-1157.2002.40501.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  30 in total

1.  SCN1A in SMEI, ICEGTC, and GEFS+: Alphabet Soup or Emerging Genotypic-Phenotypic Clarity?

Authors:  Carl E. Stafstrom
Journal:  Epilepsy Curr       Date:  2003-11       Impact factor: 7.500

2.  Reversing nerve cell pathology by optimizing modulatory action on target ion channels.

Authors:  Jenny Tigerholm; Erik Fransén
Journal:  Biophys J       Date:  2011-10-19       Impact factor: 4.033

3.  Time-dependent molecular memory in single voltage-gated sodium channel.

Authors:  Tapan K Nayak; S K Sikdar
Journal:  J Membr Biol       Date:  2007-09-01       Impact factor: 1.843

4.  Novel, broad-spectrum anticonvulsants containing a sulfamide group: pharmacological properties of (S)-N-[(6-chloro-2,3-dihydrobenzo[1,4]dioxin-2-yl)methyl]sulfamide (JNJ-26489112).

Authors:  David F McComsey; Virginia L Smith-Swintosky; Michael H Parker; Douglas E Brenneman; Ewa Malatynska; H Steve White; Brian D Klein; Karen S Wilcox; Michael E Milewski; Mark Herb; Michael F A Finley; Yi Liu; Mary Lou Lubin; Ning Qin; Allen B Reitz; Bruce E Maryanoff
Journal:  J Med Chem       Date:  2013-11-11       Impact factor: 7.446

5.  Net worth of networks: specificity in anticonvulsant action.

Authors:  Calvin J Schneider; Ivan Soltesz
Journal:  Epilepsy Curr       Date:  2015 Jan-Feb       Impact factor: 7.500

6.  Lidocaine and carbamazepine inhibit while phenytoin and lamotrigine paradoxically enhance the insect neuromuscular transmission.

Authors:  Irina M Fedorova; Denis B Tikhonov
Journal:  Invert Neurosci       Date:  2019-02-08

7.  Brevetoxin activation of voltage-gated sodium channels regulates Ca dynamics and ERK1/2 phosphorylation in murine neocortical neurons.

Authors:  Shashank M Dravid; Daniel G Baden; Thomas F Murray
Journal:  J Neurochem       Date:  2004-05       Impact factor: 5.372

8.  Fine mapping of a seizure susceptibility locus on mouse Chromosome 1: nomination of Kcnj10 as a causative gene.

Authors:  Thomas N Ferraro; Gregory T Golden; George G Smith; James F Martin; Falk W Lohoff; Tracy A Gieringer; Deborah Zamboni; Candice L Schwebel; Danielle M Press; Stephanie O Kratzer; Hongyu Zhao; Wade H Berrettini; Russell J Buono
Journal:  Mamm Genome       Date:  2004-04       Impact factor: 2.957

9.  Anticonvulsant effect of BmK IT2, a sodium channel-specific neurotoxin, in rat models of epilepsy.

Authors:  R Zhao; X-Y Zhang; J Yang; C-C Weng; L-L Jiang; J-W Zhang; X-Q Shu; Y-H Ji
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

10.  Three ENU-induced neurological mutations in the pore loop of sodium channel Scn8a (Na(v)1.6) and a genetically linked retinal mutation, rd13.

Authors:  David A Buchner; Kevin L Seburn; Wayne N Frankel; Miriam H Meisler
Journal:  Mamm Genome       Date:  2004-05       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.